Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis
Authors
Keywords
Adverse events, Bisphosphonates, Gastrointestinal safety, Osteoporosis
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 25, Issue 4, Pages 1225-1235
Publisher
Springer Nature
Online
2013-11-27
DOI
10.1007/s00198-013-2576-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Menopause: Executive Summary of Recommendations
- (2013) Neil Goodman et al. Endocrine Practice
- Efficacy of osteoporosis therapies in a network meta-analysis with indirect comparisons: many concerns for new tools of evidence synthesis?
- (2013) F. Catalá-López et al. OSTEOPOROSIS INTERNATIONAL
- Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management
- (2012) Kurt A. Kennel et al. MAYO CLINIC PROCEEDINGS
- Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis
- (2012) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women
- (2011) Robert B Hopkins et al. BMC MUSCULOSKELETAL DISORDERS
- Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture
- (2011) Steven Boonen et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Algorithmic parameterization of mixed treatment comparisons
- (2011) Gert van Valkenhoef et al. STATISTICS AND COMPUTING
- Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2
- (2011) David C. Hoaglin et al. VALUE IN HEALTH
- Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1
- (2011) Jeroen P. Jansen et al. VALUE IN HEALTH
- 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
- (2010) A. Papaioannou et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, exploratory study
- (2009) Jonathan D. Adachi et al. CLINICAL THERAPEUTICS
- Osteoporosis treatments and adverse events
- (2009) Daniel H Solomon et al. CURRENT OPINION IN RHEUMATOLOGY
- Indirect comparison: relative risk fallacies and odds solution
- (2009) Simon Eckermann et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass
- (2009) Michael McClung et al. OBSTETRICS AND GYNECOLOGY
- Comparative gastrointestinal safety of weekly oral bisphosphonates
- (2009) S. M. Cadarette et al. OSTEOPOROSIS INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now